News

By Marisa Moura Momoli

Life sciences patent eligibility in Latin America: a guide

Patents are critical to the life sciences industry and often spark intense and heated debate. To be successful, one key strategy that should be pursued by life sciences companies is building and maintaining a patent portfolio capable of distinguishing itself from competitors, as well as representing a well-reasoned business strategy. Companies should secure their patent assets by maximising patent coverage of the core technology and its potential improvements. One reason is that patents can demonstrate the commercial potential of a company’s technology, they are also the driving force for major events in the lifecycle of a life sciences company.

Access the full guide, published by IAM and written by Priscila Kashiwabara, Marisa Momoli and Livia Figueiredo by clicking here.
Back

Last by Marisa Moura Momoli

15 de April de 2025

Federal Senate approves Bill Extending Plant Variety Protection Term, but Chamber of Deputies Approval is Still Required

The Federal Senate has approved a bill (PLS nº 404/2018) that extends the protection period for new plant varieties (cultivars). According to Federal Senate approves Bill Extending Plant Variety Protection Term, but Chamber of Deputies Approval is Still Required

Ler notícia

2 de December de 2024

Brazil’s Chamber of Deputies approves adhesion to the Budapest Treaty

On November 27, 2024, the Chamber of Deputies approved Bill 466/2022, which addresses Brazil’s adhesion to the Budapest Treaty on the International Brazil’s Chamber of Deputies approves adhesion to the Budapest Treaty

Ler notícia

9 de September de 2024

Kasznar Leonardos wins LMG Life Sciences

We are honored to announce that Kasznar Leonardos has won the Firm of the Year: Brazil award at the LMG Life Sciences! Kasznar Leonardos wins LMG Life Sciences

Ler notícia
plugins premium WordPress